UBS Group’s Silicon Laboratories SLAB Stock Holding History

UBS Group’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,600	Closed	-$1.02M	–	8128
2017 Q4	$1.02M	Buy	+11,600	New	+$1.04M	﹤0.01%	3768

Other funds holding SLAB

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Pathstone Holdings Englewood, New Jersey $36.2B AUM 20.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

UBS Group's SLAB Position: Q3 2026 in Review

UBS Group increased its Silicon Laboratories (SLAB) stake by 24% in Q3 2026, buying an estimated $40.3M and bringing the position to 953,967 shares worth $211M. The position accounts for 0.03% of the portfolio, ranked #630.

UBS Group first reported a position in SLAB in Q4 2014 and has held it in 48 quarters since. 272 funds tracked by Wall St. Rank hold SLAB as of Q3 2026.

UBS Group held 953,967 shares of Silicon Laboratories worth $211M as of Q3 2026.
UBS Group bought 184,187 Silicon Laboratories shares in Q3 2026, an estimated $40.3M.
Silicon Laboratories made up 0.03% of UBS Group's portfolio in Q3 2026, its #630 holding.
UBS Group first reported a position in Silicon Laboratories in Q4 2014 and has held it in 48 quarters since.
272 funds tracked by Wall St. Rank held Silicon Laboratories as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.